Global Epilepsy Surgery Market Outlook, 2030

The global epilepsy surgery market is experiencing consistent growth due to the rising incidence of epilepsy worldwide and improvements in surgical methods. Epilepsy is a neurological condition that affects millions around the globe, marked by frequent seizures that considerably influence a patient’s quality of life. Although medication serves as the primary treatment, nearly 30–40% of epilepsy patients do not respond to pharmaceutical therapies, making surgery a feasible alternative. Epilepsy surgery includes procedures aimed at removing or modifying the brain regions responsible for seizures, thus reducing or eliminating seizure occurrences. The increasing prevalence of drugresistant epilepsy (DRE) has resulted in a higher demand for surgical interventions, such as resective surgery, laser interstitial thermal therapy (LITT), and neurostimulation methods. The implementation of robotassisted surgery, minimally invasive methods, and advanced imaging technologies has further enhanced the market. Healthcare facilities and dedicated epilepsy centers are progressively incorporating these technologies to better surgical results and reduce complications.

The global epilepsy surgery market stood at around USD 944 million in 2021 and is projected to rise to a worth of USD 1,392 million by 2028 end, thereby garnering of 5.7% during 2022-028. Moreover, greater awareness, governmental initiatives, and increasing healthcare spending are facilitating market growth. Numerous countries are funding epilepsy treatment programs, enhancing access to surgical options for patients who might otherwise be unable to afford them. Nonetheless, the high expenses related to epilepsy surgery, restricted access to skilled practitioners in developing areas, and risks linked to brain surgery present obstacles to market growth. Innovations such as stereoelectroencephalography (SEEG), deep brain stimulation (DBS), and responsive neurostimulation (RNS) are transforming the field. These methods provide personalized treatment strategies, making epilepsy surgery more secure and effective. Additionally, investigations into gene therapy and artificial intelligence (AI) in epilepsy diagnostics are anticipated to create new avenues for market expansion.

North America, especially the United States and Canada, dominates the market because of wellestablished epilepsy centers, robust reimbursement policies, and a high rate of adoption of advanced surgical techniques. The U. S. has a significant number of specialized epilepsy centers that provide minimally invasive procedures like laser interstitial thermal therapy (LITT) and deep brain stimulation (DBS). Moreover, research institutions in the U. S. are leading the way in creating AIpowered diagnostic tools and roboticassisted surgeries, which further promotes market growth. Europe captures a vital market share, with Germany, the United Kingdom, and France being the primary contributors. The region benefits from government funding for epilepsy research, increasing awareness campaigns, and access to highly skilled neurosurgeons. European nations have experienced a heightened adoption of neurostimulation devices and various innovative surgical methods. The presence of major medical technology companies also fosters innovation in epilepsy surgery. AsiaPacific is witnessing swift growth in the epilepsy surgery market, driven by rising healthcare investments, enhancing awareness, and improving surgical skills. China, Japan, and India are the leading nations in this area. China has observed progress in robotassisted epilepsy surgery, while Japan takes the lead in implementing precision medicine for neurological disorders. In India, affordable options for epilepsy treatment and increasing medical tourism are aiding in market advancement. Other developing markets, including Latin America and the Middle East and Africa, are slowly investing in epilepsy treatment facilities, although restricted access to specialized epilepsy surgery continues to pose a challenge in these areas.

Laser Interstitial Thermal Therapy (LITT) has become popular owing to its minimally invasive characteristics, reduced hospital stays, and faster recovery times. LITT utilizes focused laser energy to obliterate seizureinducing brain tissue, rendering it an optimal choice for individuals with lesionbased epilepsy. The growing employment of robotic assistance and realtime MRI guidance has additionally enhanced precision and safety during LITT procedures. Resective surgery continues to be the gold standard for surgical intervention in epilepsy, particularly for patients with focal epilepsy where the seizure source can be distinctly identified. This method entails extracting the section of the brain that triggers seizures, such as the temporal lobectomy, frontal lobectomy, or lesionectomy. It boasts a high success rate, with numerous patients attaining longterm seizure management. However, its invasive aspects and associated risks have prompted some patients to choose less invasive alternatives. Other procedures include DBS and RNS, which have gained popularity in scenarios where conventional resective surgery is not an option. DBS consists of implanting a device that transmits electrical impulses to targeted brain regions, aiding in seizure control. RNS serves as an adaptive neuromodulation system that perceives irregular brain activity and provides electrical stimulation to avert seizures prior to their onset. Both techniques deliver customized and enduring seizure management options for patients potentially ineligible for tissue removal surgeries.

Hospitals and Clinics serve as the primary providers of epilepsy surgery, particularly in developed areas that have access to advanced medical technology. Large hospitals frequently feature dedicated epilepsy centers where specialized neurosurgeons, neurophysiologists, and imaging experts collaborate to create personalized treatment plans. Teaching hospitals and research organizations also make substantial contributions to the market by experimenting with new surgical techniques and creating innovative technologies. Many hospitals are now incorporating robotassisted and AIdriven neurosurgical devices to improve surgical accuracy and patient results. Specialty Centers, like comprehensive epilepsy treatment centers, are gaining prominence due to their focused approach on epilepsy care. These facilities typically contain multidisciplinary teams that provide advanced diagnostic evaluations, tailored surgical strategies, and rehabilitation following surgery. Specialty centers are particularly advantageous for intricate epilepsy cases, where thorough presurgical assessments using stereoelectroencephalography (SEEG) or functional MRI are necessary prior to surgery. The increasing demand for minimally invasive techniques has led specialty centers to incorporate LITT, DBS, and neurostimulation treatments at an escalating pace. Other facilities, including private clinics, ambulatory surgery centers (ASCs), and research institutions, are also playing a part in the epilepsy surgery market. ASCs provide sameday surgical procedures for less invasive treatments such as LITT and are favored by patients looking for shorter hospital stays and lower healthcare costs. Research institutions, conversely, are propelling clinical trials, technological advancements, and neurosurgical innovations, influencing the development of epilepsy surgery.



Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Global Epilepsy Surgery Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By procedure type:
• laser interstitial thermal therapy (LITT)
• resective surgery
• others

By end user:
• hospitals & clinics
• specialty centers
• others
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.